missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BCR Antibody (1E11G12) - BSA Free, Novus Biologicals™
  7. 18628576

BCR Antibody (1E11G12) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-61707-0.025ml

 View more versions of this product

Product Code. 18628576

  • 2115.00 NOK / 0.03mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

BCR Monoclonal specifically detects BCR in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

BCR
Monoclonal
1 mg/mL
Western Blot 1:500-1:2000, Flow Cytometry 1:200-1:400, ELISA 1:10000
ALLD22S11, BCR1, breakpoint cluster region, breakpoint cluster region protein, CMLEC 2.7.11.1, D22S662, PHLFLJ16453, Renal carcinoma antigen NY-REN-26
Mouse
142.8 kDa
0.025 mL
Primary
Human, Mouse
Purified
Western Blot, Flow Cytometry, ELISA
1E11G12
Unconjugated
PBS with 0.05% Sodium Azide
BCR
Purified recombinant fragment of human BCR (AA: 139-280) expressed in E. Coli.
Protein G purified
Phospho Specific, Protein Kinase, Signal Transduction
613
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.